17-219721-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_006987.4(RPH3AL):​c.629G>A​(p.Ser210Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 29)

Consequence

RPH3AL
NM_006987.4 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.88
Variant links:
Genes affected
RPH3AL (HGNC:10296): (rabphilin 3A like (without C2 domains)) The protein encoded by this gene plays a direct regulatory role in calcium-ion-dependent exocytosis in both endocrine and exocrine cells and plays a key role in insulin secretion by pancreatic cells. This gene is likely a tumor suppressor. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.33146828).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RPH3ALNM_006987.4 linkc.629G>A p.Ser210Asn missense_variant 8/10 ENST00000331302.12 NP_008918.1 Q9UNE2-1
RPH3ALNM_001190411.2 linkc.629G>A p.Ser210Asn missense_variant 7/9 NP_001177340.1 Q9UNE2-1
RPH3ALNM_001190412.2 linkc.542G>A p.Ser181Asn missense_variant 7/9 NP_001177341.1 Q9UNE2-2A8K7D5
RPH3ALNM_001190413.2 linkc.542G>A p.Ser181Asn missense_variant 6/8 NP_001177342.1 Q9UNE2-2A8K7D5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RPH3ALENST00000331302.12 linkc.629G>A p.Ser210Asn missense_variant 8/102 NM_006987.4 ENSP00000328977.7 Q9UNE2-1

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
29

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 22, 2022The c.629G>A (p.S210N) alteration is located in exon 8 (coding exon 6) of the RPH3AL gene. This alteration results from a G to A substitution at nucleotide position 629, causing the serine (S) at amino acid position 210 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T;T;.;.
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Benign
0.50
N
LIST_S2
Benign
0.76
T;.;.;T
M_CAP
Benign
0.0040
T
MetaRNN
Benign
0.33
T;T;T;T
MetaSVM
Benign
-0.57
T
MutationAssessor
Uncertain
2.2
M;M;.;.
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.0
.;.;.;N
REVEL
Benign
0.10
Sift
Uncertain
0.0060
.;.;.;D
Sift4G
Benign
0.12
T;T;T;T
Polyphen
0.98
D;D;D;D
Vest4
0.40
MutPred
0.33
Loss of phosphorylation at S210 (P = 0.0015);Loss of phosphorylation at S210 (P = 0.0015);.;.;
MVP
0.56
MPC
0.26
ClinPred
0.90
D
GERP RS
3.5
Varity_R
0.31
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-69512; API